Unpacking the Latest Options Trading Trends in Humacyte
Portfolio Pulse from Benzinga Insights
Recent options trading trends in Humacyte (NASDAQ:HUMA) show a bearish stance among large investors, with 62% of trades being bearish. The stock is currently down by 15.99% at $6.64, with an RSI suggesting it may be approaching oversold territory. Analysts have mixed ratings, with target prices ranging from $11 to $15.
August 12, 2024 | 7:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Humacyte (NASDAQ:HUMA) has seen a bearish trend in options trading, with 62% of trades being bearish. The stock is down 15.99% at $6.64, and analysts have mixed ratings with target prices ranging from $11 to $15.
The majority of options trades are bearish, indicating negative sentiment among large investors. The stock's significant drop and mixed analyst ratings further support a likely short-term decline.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100